UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Stesolid® Rektal Prefill 5 mg/ml Rektallösning
- Invented name part: Stesolid®
- Strength part: 5 mg/ml
- Pharmaceutical dose form part: Rektallösning
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Rectal solution
Legal status of supply: Medicinal product subject to special medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 9307
Region: Kingdom of Sweden
Marketing authorisation holder: Actavis Group PTC ehf.
Identifier:
Status: Valid (1978-03-03)
Package 1 of 1
PCID:
Description: Rektalspruta, 5 x 2 ml
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 5 Pre-filled syringe (Glass type I) (Bromobutyl rubber) (Chlorobutyl rubber) (Polystyrene) (Low Density PolyEthylene)
Containing: 2 milligram(s)
Manufactured Item
Dose form: Rectal solution
Unit of presentation: Syringe
Ingredient
Role: Active
Substance: Diazepam
Concentration strength: 5 milligram(s) / 1 milliliter(s)
Reference strength: Diazepam 5 milligram(s) / 1 milliliter(s)
Administrable Product (1 of 1)
Dose form: Rectal solution
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: Diazepam
Concentration strength: 5 milligram(s) / 1 milliliter(s)
Reference strength: Diazepam 5 milligram(s) / 1 milliliter(s)